The National Council on Radiation Protection and Measurement
(NCRP) released a new publication (NCRP Report No. 132, December 2000)
that provides radiation protection guidance and radiation exposure limit
recommendations for astronauts working in low-earth orbit. In response to
NASA's request, the NCRP Scientific Committee-75 prepared this report. Dr.
R. J. Michael Fry of the Oak Ridge National Laboratories who served as the
Chairman of the Scientific Committee-75 emphasized that, "The guidance
in this Report (no. 132) supersedes the radiation exposure limit
recommendations provided in NCRP Report No. 98 that was published in
1989."
Table-1: Radiation Dose Limits for Deterministic
Effects Defined a Decade Apart
Short-term radiation dose limits for the eye, skin, and BFO (Blood Forming Organs) are presented and compared from the 1989 and 2000 NCRP reports. NASA’s 30-day and 1-year radiation dose limits, which are defined for preventing deterministic radiation effects have been based on the recommendations from NCRP Report No. 98 (1989). The NCRP in their recently released report, NCRP Report No. 132 (2000), proposed the implementation of limits for preventing deterministic radiation effects that incorporates a relative biological effectiveness, RBE for such effects are expressed as gray-equivalent, Gy-Eq. This is a significant change from the prior use of radiation quality factors, Q that are based on data for late-effects, most importantly cancer, although few studies with HZE (High Z=atomic number and Energy) particles have been made for determining both short-term and career limits. Based on these new NCRP recommendations, more emphasis on research for determining the appropriate RBE values for deterministic effects will be needed. As shown in Table-1 there is no change in the values for short-term dose limits recommended in the new report.
Table-2: Career Radiation Dose Limits for Late
Effects Defined a Decade Apart
Career dose limits (in Sv) corresponding to probability of 3% excess cancer mortality for a 10-year career are shown in Table-2. These limits are dependent on the age and gender with values from both the NCRP No.98 (1989) and NCRP No.132 (2000) listed. In the new NCRP recommendations, the doses corresponding to the 3% fatal risk for males and females are reduced significantly based on the findings from more recent analysis of the survivors of the atomic-bomb explosions during World War II and other exposed cohorts.
In the above two charts, career exposure limits (NCRP-98 vs. NCRP-132) for a lifetime excess risk of fatal cancer of 3% as a function of age at exposure are shown. Changes in the methodologies for organ-dose evaluations, discussion of the higher average quality factors that are now known to occur in low Earth orbit, and research needs in radiobiology, environments, and dosimetry are also discussed in the new report.
In the very near future, the 2001 Mars Odyssey (launched on April 7th, 2001 and expected to arrive Mars by October 24th, 2001) will be gathering the first Martian radiation environment data with the MARIE (Martian Radiation Environment Experiment) instrument. The MARIE instrument was designed and developed from the NASA Johnson Space Center by a team led by the PI, Dr. Gautam D. Badhwar. Though the original radiation measurement plans included an instrument to be placed on the lander, from the current 2001 Mars Odyssey Mission, such measurements from the lander have been curtailed and MARIE instrument will collect data from the orbiter. The first radiation measurements of the GCR environment en route to Mars are expected from the MARIE instrument during the later part of April-2001. The first measurements of the Martian radiation environment are expected during the later of the year 2001. Some of these radiation measurements from the MARIE instrument will be made available in the year 2002. More information and description of the MARIE instrument from the PI, Dr. Badhwar is also available.
The First ISS Expedition Crew (2R – 5A.1) returned to earth after spending 136 days on the ISS. The Second ISS Expedition Crew (5A.1 – 7A.1) is expected to spend about 126 days. During the current solar cycle we have been experiencing several Solar Flares including a flare on April 2nd the most powerful solar flare in 25 years. However, only a minor solar particle event occurred from this solar flare and it did not have any impact on the ISS crewmembers and their health. At this time, providing ISS crewmembers with shielding augmentation approaches using hydrogen rich materials has been a primary goal for the Space Radiation Health Project.
During January 8-15, 2001, the SRHP sponsored a series of radiobiological and physics experiments utilizing the Brookhaven National Laboratory’s (BNL) Alternating Gradient Synchrotron (AGS) facility with iron ion beam. These experiments were part of the seventh consecutive radiobiology investigations (BNL-7). For BNL-7, a total of 24 different proposals and 81 users were supported that represented 19 U.S. institutions and five international collaborators (from Italy, Japan, and U.K.). More than 1600 biological samples were irradiated with iron beam. Typical 56Fe beam used for majority of the radiobiology studies included the following: 56Fe beam = 1.046 GeV/nucleon with LET 148 keV/µm and dose rate range from 10 cGy/min to 15 Gy/min. Results and analysis from these studies are forth coming. An executive summary of BNL-7 is also available.
![]()
Featured Investigator
More than 15 years ago, Dr. Iliakis joined the Thomas Jefferson University as an Associate Professor of Radiation Therapy and Nuclear Medicine. At present, Dr. Iliakis serves as a Professor of Radiation Oncology and as the Director for the Division of Experimental Radiation Oncology, Kimmel Cancer Center of the Jefferson Medical College. Prior to the work at the Thomas Jefferson University, Dr. Iliakis also served as Project Scientist at the Cleveland Clinic Foundation, Ohio. Dr. Iliakis’s educational background includes: M. Sc., in physics (1975) from the University of Athens, Greece; and a Ph. D., in biophysics (1978) from the University of Frankfurt/Main, Germany. During the past two decades as a distinguished research scientist, Dr. Iliakis served as a principal investigator on several research grants supported by the National Institute of Health (NIH), the National Cancer Institute (NCI), and NASA. Dr. Iliakis also served as the Associate Editor of Radiation Research and International Journal of Radiation Biology. At present, Dr. Iliakis serves as an associate editor for the journal of Radiation Environmental Biophysics and also as the president of the Philadelphia Cancer Research Association. Dr. Iliakis authored or co-authored more than 120 peer reviewed research publications. See the enclosed short CV on his most recent studies of the radiation induced cell damage. Most recently, Dr. Iliakis became the vice-President elect of the Radiation Research Society, and will have the honor to serve this Society as president in 2003. Dr. Iliakis notes on his research as follows: “During the last 20 years the central goal of my research was the elucidation of the chain of events that leads from damage induction in the DNA to chromosome damage and ultimately to cell death. Induction and repair of DNA double stranded breaks was studied extensively, and was complemented by measurements of induction and repair of inter-phase chromosome breaks. At the cell level, cellular repair reactions including repair of potentially lethal and repair of sub-lethal damage have been studied, together with the mechanism of the cell cycle dependent fluctuations in radiosensitivity. My laboratory was the first to show the presence of different forms of potentially lethal damage in cells exposed to sparsely ionizing radiation, and the first to propose that variations in the fixation of this type of damage causes the fluctuations in radiosensitivity throughout the cell cycle. Recent work focuses on the genetics and the biochemistry of the repair of DNA double strand breaks, as well as in the elucidation of S-phase checkpoint.” See for more description of the research. One of the current NASA funded studies with Dr. Iliakis as the principal investigator is a study on understanding the radiation damage process and repair mechanism at various cell cycle phases, “Factors Modulating Radiation-Induced G-2 Delays.” Results from these investigations are expected to provide data for assessing the radiation damage process at the cell level and develop appropriate counter measures to minimize the radiation induced cancer risk. Some of the preliminary results and current research progress shows such a promise. See the list of research publications (2000-2001) on this on-going NASA supported research.
Low Dose Radiation Research Program of Department of Energy (DOE) and Space Radiation Health Program of NASA are conducting a joint workshop and NASA’s 12th Annual Radiation Investigators Meeting. Registration and abstract submission details are available on-line. Also, NASA investigators travel awards application material is available.
![]() | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||